Persistence with Cholinesterase Inhibitor Treatment in Alzheimer's Disease

被引：4
|
作者：
Massoud, Fadi [1 ]
机构：
[1] Univ Montreal, Montreal, PQ, Canada
来源：
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES | 2013年 / 40卷 / 05期
关键词：
DEMENTIA; DISCONTINUATION; THERAPY;
D O I：
10.1017/S0317167100014815
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：623 / 624
页数：2
相关论文
共 50 条
  • [21] Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
    Tayeb, Haythum O.
    Yang, Hyun Duk
    Price, Bruce H.
    Tarazi, Frank I.
    PHARMACOLOGY & THERAPEUTICS, 2012, 134 (01) : 8 - 25
  • [22] Risk Factors for Nursing Home Placement in Alzheimer's Disease: A Longitudinal Study of Cognition, ADL, Service Utilization, and Cholinesterase Inhibitor Treatment
    Wattmo, Carina
    Wallin, Asa K.
    Londos, Elisabet
    Minthon, Lennart
    GERONTOLOGIST, 2011, 51 (01): : 17 - 27
  • [23] Cholinesterase Inhibitor Discontinuation in Patients With Alzheimer's Disease: A Meta-Analysis of Randomized Controlled Trials
    O'Regan, Jordana
    Lanctot, Krista L.
    Mazereeuw, Graham
    Herrmann, Nathan
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (11) : E1424 - +
  • [24] Cholinesterase inhibitor rivastigmine enhance the mitochondrial electron transport chain in lymphocytes of patients with Alzheimer's disease
    Casademont, J
    Miró, O
    Rodriguez-Santiago, B
    Viedma, P
    Blesa, R
    Cardellach, F
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 206 (01) : 23 - 26
  • [25] Long-term Outcome and Prediction Models of Activities of Daily Living in Alzheimer Disease With Cholinesterase Inhibitor Treatment
    Wattmo, Carina
    Wallin, Asa K.
    Londos, Elisabet
    Minthon, Lennart
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2011, 25 (01): : 63 - 72
  • [26] Pioglitazone for the treatment of Alzheimer's disease
    Galimberti, Daniela
    Scarpini, Elio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (01) : 97 - 101
  • [27] Acetylcholinesterase inhibitor treatment for Alzheimer's disease: the experience in Picardy.
    Magnier, V
    Flipon, E
    Godefroy, O
    Ganry, O
    Dupuy-Sonntag, D
    Rosa, A
    REVUE NEUROLOGIQUE, 2005, 161 (02) : 211 - 213
  • [28] How useful are cholinesterase inhibitors in the treatment of Alzheimer's Disease? A number needed to treat analysis
    Livingston, G
    Katona, C
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2000, 15 (03) : 203 - 207
  • [29] Hemodynamic effects of cholinesterase inhibition in mild Alzheimer's disease
    Chaudhary, Simone
    Scouten, Amy
    Schwindt, Graeme
    Janik, Rafal
    Lee, Wayne
    Sled, John G.
    Black, Sandra E.
    Stefanovic, Bojana
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2013, 38 (01) : 26 - 35
  • [30] CHOLINESTERASE INHIBITORS AND MEMANTINE FOR THE TREATMENT OF ALZHEIMER AND NON-ALZHEIMER DEMENTIAS
    Balazs, Nora
    Bereczki, Daniel
    Kovacs, Tibor
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2021, 74 (11-12): : 379 - 387
12345